The choice of papaya leaves was not arbitrary. The researchers identified three specific reasons for preferring this botanical precursor over other biomass. First, papaya leaves are unusually rich in nitrogen-bearing alkaloids such as carpaine and pseudocarpaine, along with flavonoid glycosides, which provide in-situ nitrogen doping of the carbon dots without requiring an external dopant like ethylenediamine. Second, the high polyphenol and ascorbate content supplies the reducing equivalents needed to convert cerium(III) into cerium oxide at just 65 degrees Celsius, which is what makes the calcination-free route possible. Third, as a non-food agricultural residue available year-round, papaya leaves avoid competing with food uses in the way that fruit-pulp and seed precursors do. The leaves were shade-dried at ambient temperature for seven days rather than oven-dried, a deliberate choice to preserve the heat-sensitive polyphenols and ascorbate that drive the reduction chemistry.

The synthesis proceeded in two parallel tracks. For the carbon dots, a filtered aqueous extract was sealed in a Teflon-lined autoclave and heated at 180 degrees Celsius for six hours, triggering the dehydration, polymerization and carbonization of phytochemicals into fluorescent, water-dispersible carbon nanoparticles. For the cerium oxide, cerium(III) nitrate solution was heated to 65 degrees Celsius, treated dropwise with fresh papaya extract, and adjusted to pH 10 with sodium hydroxide; the plant polyphenols reduced and capped the growing particles without any subsequent high-temperature annealing. The two components were then combined by ultrasonication, which promoted electrostatic and chemical interaction between the oxide surfaces and the carbon dot corona, yielding the final CeO₂@CD nanohybrid after centrifugation and washing.

Characterization revealed an intimate hybrid rather than a simple physical mixture. Powder X-ray diffraction confirmed phase-pure cubic fluorite cerium oxide with no extraneous cerium hydroxide or sesquioxide phases, while the pristine carbon dots showed a completely featureless, amorphous diffraction profile. The mean crystallite size of the oxide domains in the composite was just 3.47 nanometers, slightly smaller than the 4.40 nanometers measured for the pristine oxide, indicating that the carbon dot matrix confines crystallite growth during fabrication. Energy-dispersive X-ray spectroscopy gave an atomic composition of 38.66 percent carbon, 43.13 percent oxygen and 18.21 percent cerium, and full-field elemental mapping over a five-micrometer field showed all three elements uniformly distributed with no segregation into separate domains. Dynamic light scattering placed the hydrodynamic diameter at 84.2 nanometers with a zeta potential of minus 13.6 millivolts, confirming that the dispersed entity is an assembly of many primary crystallites within a common carbon-dot corona.

Optical measurements explained why the hybrid responds to sunlight at all. Tauc analysis of the absorption edge gave a direct optical band gap of 3.26 electron volts, essentially unchanged from bulk ceria, meaning the carbon dots do not narrow the fundamental gap. Instead, the composite exhibits a weak sub-edge absorption tail extending to roughly 550 nanometers, attributed to carbon-dot-derived mid-gap states and oxygen-vacancy Ce³⁺ defect levels. It is this tail, together with direct excitation across the fundamental edge by the near-ultraviolet component of sunlight, that drives the visible-light activity. Beyond 600 nanometers the material absorbs essentially nothing, so the photocatalysis is powered by the blue-green portion of the solar spectrum rather than the full visible range.

That activity proved impressive. Under natural sunlight, the nanohybrid decolorized 95 percent of methylene blue within 90 minutes at pH 10, following pseudo-first-order kinetics with a rate constant of 0.0333 per minute and a correlation coefficient exceeding 0.999. A striking 22.6 percent of the dye was removed by dark adsorption alone before illumination, thanks to the negatively charged, oxygen-functionalized carbon dot surface attracting the cationic dye. Radical-trapping experiments identified superoxide radicals as the dominant oxidant, contributing 29.3 percent of the activity, followed by hydroxyl radicals at 19.7 percent and photogenerated holes at 13.8 percent. Photoluminescence measurements provided direct evidence for the underlying charge-separation mechanism: the composite’s peak emission was quenched by 9.8 percent relative to pristine ceria, and its average carrier lifetime lengthened from 2.30 to 3.72 nanoseconds, showing that photogenerated electrons and holes escape radiative recombination long enough to reach the surface and drive redox chemistry. The catalyst retained 91.6 percent of its initial activity over five consecutive cycles, with the rate of deactivation diminishing from cycle to cycle in a pattern consistent with reversible surface fouling rather than structural breakdown.

The biological results were equally striking. In antioxidant assays, the nanohybrid achieved an IC₅₀ of 56.6 micrograms per milliliter against DPPH radicals and 48.4 micrograms per milliliter against ABTS radicals, the latter actually outperforming the ascorbic acid reference standard. Against a panel of four bacterial strains, the material produced inhibition zones ranging from 21.08 millimeters for Staphylococcus aureus to 37.46 millimeters for Bacillus subtilis, with minimum inhibitory concentrations between 10.86 and 19.74 micrograms per milliliter and a uniform minimum bactericidal concentration of 28.0 micrograms per milliliter. Compared with the ciprofloxacin reference, the nanohybrid showed comparable or superior potency, particularly against Bacillus subtilis. The authors attribute this broad-spectrum activity to reactive oxygen species generated by the Ce³⁺/Ce⁴⁺ redox couple damaging bacterial membranes, proteins and DNA, with the carbon dot component additionally interfering with bacterial protein synthesis.

Perhaps the most consequential findings came from the mammalian cell studies. In non-cancerous HEK-293T kidney cells, viability remained above 91 percent even at 200 micrograms per milliliter after 96 hours, and the median cytotoxic concentration exceeded 600 micrograms per milliliter, the highest concentration tested. Yet against MCF-7 breast adenocarcinoma cells the nanohybrid achieved an IC₅₀ of 9.86 micrograms per milliliter, and against PC-3 prostate carcinoma cells an IC₅₀ of 11.64 micrograms per milliliter, figures approaching the doxorubicin chemotherapy benchmark of 8.12 micrograms per milliliter. The resulting selectivity indices, greater than 60.9 for MCF-7 and greater than 51.5 for PC-3, both exceed the threshold of 50 conventionally associated with very high therapeutic potential, meaning the material kills cancer cells at concentrations more than fiftyfold below those that harm normal cells. This selectivity is understood to arise from the pro-oxidant surface chemistry of nanoscale, oxygen-deficient ceria, which tips the already elevated redox balance of rapidly dividing cancer cells toward apoptosis while sparing healthier cells.

The authors are candid about the study’s limitations. Reference diffraction and infrared spectra of the pristine components are still being acquired for a complete comparison, the influence of initial dye concentration and illuminated area on photocatalysis was not mapped, and colloidal characterization was performed only in pure water rather than in saline or culture medium, where protein corona formation would be expected to alter surface properties. Post-cycling structural analysis of the recovered catalyst also remains to be done. Even so, the convergence of environmental and biomedical functionality in a single, sustainably fabricated material is notable. Most photocatalysts are engineered purely for remediation, and most therapeutic nanomaterials are never tested against environmental pollutants; CeO₂@CD was evaluated across both domains with the same batch of material. The papaya-derived nanohybrid also compares favorably with ceria photocatalysts biosynthesized from Spirulina and neem extracts, which reported roughly 92 and 89 percent methylene blue removal respectively under comparable conditions. If subsequent work confirms the colloidal stability in physiological media and optimizes the carbon dot synthesis parameters, this humble leaf waste could seed a genuinely dual-purpose platform, one that cleans industrial wastewater on Monday and, in a different formulation, helps oncologists on Tuesday.

Subject of Research: Green synthesis of a multifunctional cerium oxide–carbon dot nanohybrid from Carica papaya for photocatalytic dye degradation and biomedical applications

Article Title: Green cerium oxide–carbon dot nanohybrid (CeO₂@CD) from Carica papaya : photocatalytic degradation and antibacterial, antioxidant, cytotoxic, and anticancer activities

Article References: Lakkaboyana, S. K., & Adam, S. U. (2026). Green cerium oxide–carbon dot nanohybrid (CeO₂@CD) from Carica papaya: photocatalytic degradation and antibacterial, antioxidant, cytotoxic, and anticancer activities. Results in Chemistry, 31, Article 103848. https://doi.org/10.1016/j.rechem.2026.103848

Image Credits: AI Generated

DOI: 10.1016/j.rechem.2026.103848

Keywords: cerium oxide, carbon dots, Carica papaya, green synthesis, photocatalysis, methylene blue, antibacterial, anticancer, antioxidant, reactive oxygen species, nanohybrid, water remediation

The appeal of cerasomes begins with the limitations of conventional carriers. Liposomes, which are spherical structures assembled from phospholipids, can accommodate water-soluble compounds in their internal aqueous compartment and fat-soluble compounds within the membrane. They are generally biocompatible and their surfaces can be chemically modified, but they may fuse with one another, aggregate, leak their cargo and disappear rapidly from circulation. Silica nanoparticles offer a contrasting set of strengths, including structural integrity, tunable surfaces, high areas for chemical attachment and resistance to some environmental stresses. Yet purely inorganic particles can be less flexible, less biomimetic and less suitable for certain drugs. Cerasomes are designed as a compromise: a lipid-based vesicle is reinforced from the outside by an interconnected siloxane network, producing a structure that remains biologically versatile while resisting deformation and premature breakdown.

The concept traces back to work on organic–inorganic hybrid materials and to the first cerasomes reported by Katagiri and collaborators in 2007. The particles are made from specialized cerasome-forming lipids containing silicon-bearing head groups, hydrophobic hydrocarbon tails and molecular linkers. In water, these amphiphilic molecules can organize into a bilayer, much as ordinary lipids do. Their silicon-containing groups then undergo hydrolysis and condensation reactions, the central chemical steps of a sol–gel process. Hydrolysis converts reactive alkoxysilane groups into silanol groups, while condensation connects them through Si–O–Si bonds. The resulting polyorganosiloxane layer forms over the vesicle surface rather than replacing the membrane. This architecture gives the particle an organic interior and an inorganic exterior, with the thickness and properties of each component influenced by the molecular structure of the starting lipids.

The review describes two broad preparation routes. In one, cerasome-forming lipids are dispersed directly in water, often by vortex mixing, allowing vesicle formation and surface rigidification to occur in the same environment. In another, the lipids are first incubated in acidic ethanol so that their silicon-containing groups hydrolyze before the solution is injected into water. Sonication can reduce multilamellar structures and produce smaller vesicles, while subsequent incubation and drying help complete formation of the hybrid network. The exact outcome depends strongly on pH, temperature, solvent composition, precursor concentration and hydrolysis time. These variables affect condensation, particle size, surface charge, encapsulation efficiency and release kinetics. That sensitivity is scientifically useful because it permits tuning, but it also creates a reproducibility problem when researchers attempt to move from small laboratory batches to industrial production.

Once formed, a cerasome can carry several kinds of cargo at the same time or in different formulations. Hydrophilic drugs can be enclosed in the aqueous core, whereas hydrophobic compounds can lodge in the lipid region. Amphiphilic molecules can interact with both environments. The siloxane shell restricts membrane motion and creates a barrier that can reduce leakage, extending release over hours or days depending on composition and cross-linking. In examples summarized by the authors, doxorubicin-loaded cerasomes retained about 92 percent of their encapsulated drug after 90 days of storage, compared with approximately 35 percent for conventional liposomes. Paclitaxel-loaded cerasomes also released the drug more slowly than paclitaxel-loaded liposomes under laboratory conditions. Such results suggest that stability can be a practical advantage, although a release rate that is too slow could prevent enough drug from reaching its intended target.

Surface chemistry provides a second level of control. Cerasome surfaces contain reactive silanol groups that can be modified with polymers, peptides, antibodies, aptamers, fluorophores or other molecules. The review describes a route in which 3-aminopropyltriethoxysilane introduces exposed amino groups, followed by glutaraldehyde chemistry that creates attachment sites for targeting ligands and imaging agents. Polyethylene glycol can make the surface more hydrophilic, reduce aggregation and extend circulation. Folic acid, peptides and antibodies can be added to recognize receptors that are unusually abundant on particular cancer cells. HER2-directed cerasomes, for example, have been investigated as carriers for doxorubicin in HER2-positive breast cancer models. Other designs use triphenylphosphonium to direct cargo toward mitochondria, where disrupting energy production can intensify cancer-cell damage. These strategies are intended to improve selectivity, but the biological identity of any nanoparticle can change after proteins from blood coat its surface.

Cerasomes can also be engineered to respond to conditions associated with disease or intracellular trafficking. Tumour tissue and endosomal compartments are often more acidic than blood, creating an opportunity for pH-sensitive release. Redox-responsive designs exploit reducing conditions and elevated glutathione concentrations inside cells, which can cleave specially designed linkages and promote release after uptake. Temperature-sensitive formulations have been studied for treatments that use localized heating, while light-responsive systems can provide remote control where the activating wavelength can reach the tissue. Near-infrared light is attractive because it penetrates more deeply than ultraviolet or visible light, although tissue penetration remains a constraint. Ultrasound-responsive cerasomes represent another approach, allowing externally applied energy to trigger local effects. The review notes that dual-responsive particles, such as systems reacting to both pH and redox conditions, may offer finer control than single-trigger carriers.

The same structural features that make cerasomes attractive for drugs also broaden their potential uses. Positively charged cerasomes can bind plasmid DNA, small interfering RNA and other nucleic acids, while their partial ceramic coating helps prevent fusion with other vesicles and protects cargo from premature degradation. A reported cerasome–DNA complex was about 70 nanometres across, a size that can support cellular uptake and intracellular trafficking. The particles have also been explored for cancer theranostics, a combination of diagnosis and treatment. Fluorescent dyes, quantum dots, magnetic nanoparticles and porphyrins can be incorporated into or attached to the vesicles, enabling optical imaging, magnetic resonance imaging or photodynamic therapy. In vaccine delivery, the hybrid shell may protect antigens and improve storage stability, while surface ligands could help direct antigens toward antigen-presenting cells. Related investigations have considered insulin delivery, antimicrobial applications, neurodegenerative disease and precision medicine.

Yet the review’s most important message may be its account of the obstacles between promising experiments and medical products. Silica-containing materials can accumulate in organs such as the liver and spleen, so researchers must establish how composition, size, charge and surface chemistry influence toxicity, inflammation, biodistribution and elimination. Cerasomes can gradually hydrolyze, producing soluble silicic-acid species, but their degradation depends on the structure and the surrounding biological environment. Protein-corona formation may alter targeting and circulation in ways that are still poorly understood for this specific class of particles. Manufacturing presents another challenge: conventional methods can produce batch-to-batch variation in size, charge, shell formation and drug loading. Microfluidic and continuous-flow methods may improve mixing and reproducibility, while quality-by-design approaches could link manufacturing conditions to critical product properties. For now, the authors conclude, cerasomes are promising next-generation nanocarriers rather than established therapies. Standardized characterization, extensive animal studies, long-term safety testing and carefully designed clinical investigations will determine whether their unusual marriage of lipid biology and silica chemistry can deliver on its therapeutic promise.

The cerasome architecture is important because it separates several design functions within one particle. The lipid bilayer supplies a water-compatible interior and a hydrophobic domain, while the polysiloxane framework provides a chemically addressable outer surface. This compartmentalization allows researchers to select cargo according to its physicochemical properties rather than forcing every therapeutic molecule into the same environment. It also creates opportunities to adjust membrane composition, shell formation and surface chemistry independently, although changes in one component may influence the stability, permeability and biological behaviour of the whole nanostructure.

Surface functionalization can be understood as a way of regulating interactions at the biological interface. Silanol groups on the silica-containing exterior provide sites for chemical modification, potentially enabling attachment of ligands that recognize cellular receptors or polymers that alter colloidal behaviour. Such modifications do not guarantee selective delivery: targeting molecules must remain accessible in biological fluids, and the particle must still circulate, reach the relevant tissue, bind to cells and undergo uptake. Consequently, the performance of a targeted cerasome depends not only on ligand choice but also on particle size, surface charge, ligand density and the stability of the coating under physiological conditions.

The review places cerasomes within a broader progression in nanocarrier design, from single-function vesicles toward multifunctional systems that combine transport, sensing and treatment. Their ability to incorporate imaging agents alongside therapeutic or genetic cargo supports pharmacokinetic studies and theranostic concepts, in which localization and response might be monitored during treatment. At the same time, multifunctionality increases the number of properties that must be measured and controlled. Meaningful evaluation therefore requires more than demonstrating cargo loading: studies must relate shell chemistry and degradation to release, cellular uptake, biological distribution and eventual clearance. Establishing those relationships will be central to determining whether the advantages of organic–inorganic integration translate into reproducible therapeutic benefit.

Subject of Research: Nanohybrid cerasomes for targeted drug and biomedical delivery

Article Title: Nanohybrid cerasomes as silica lipid carriers for targeted therapeutics

Article References: Sabale, V., Dhage, R., Chawade, S., Kaithwas, A., Nikam, M., & Sabale, P. (2026). Nanohybrid cerasomes as silica lipid carriers for targeted therapeutics. Discover Industrial Chemistry and Materials, 1(1), Article 17. https://doi.org/10.1007/s44508-026-00018-7

Image Credits: AI Generated

DOI: 10.1007/s44508-026-00018-7

Keywords: Cerasomes, Nanomedicine, Drug delivery, Silica nanoparticles, Liposomes, Cancer therapy, Gene delivery, Theranostics, Nanohybrid, silica, lipid, carriers